Literature DB >> 6816810

T gamma (T gamma) cells suppress growth of erythroid colony-forming units in vitro in the pure red cell aplasia of B-cell chronic lymphocytic leukemia.

K F Mangan, G Chikkappa, P C Farley.   

Abstract

In vitro studies were performed in two patients with B-cell chronic lymphocytic leukemia who developed pure red cell aplasia (CLL-PRCA). During the active phase of their red cell aplasia, there was a marked reduction in the numbers of erythroid colony-forming units (CFU-E). Unfractionated sera or separated IgG fractions from these patients did not impair CFU-E proliferation from either autologous or allogeneic marrows. Increased numbers of T lymphocytes were present in marrow aspirates of these patients. Analysis of these T cells indicated that 90 and 35%, respectively, bore Fc receptors for IgG (T gamma cells). Removal of T cells by E-rosetting techniques augmented CFU-E growth in CLL-PRCA 10-fold. Similar treatment of normal marrows did not cause similar enhanced growth of CFU-E. Co-cultures of marrow T cells or T gamma cells obtained during the active phase of CLL-PRCA suppressed CFU-E growth from autologous or allogeneic marrows. After achieving drug-induced remission of the PRCA, marrow T cells were no longer inhibitory. In contrast, BFU-E (erythroid burst-forming units) or granulocyte proliferation in diffusion chambers were not suppressed by CLL-PRCA T cells. These findings suggest that the development of PRCA in B-cell CLL may result from suppression of CFU-E proliferation by T gamma cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6816810      PMCID: PMC370331          DOI: 10.1172/jci110713

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

Review 1.  Pure red-cell aplasia.

Authors:  S B Krantz
Journal:  N Engl J Med       Date:  1974-08-15       Impact factor: 91.245

2.  Immunoglobulins on the surface of neoplastic lymphocytes.

Authors:  A C Aisenberg; K J Bloch
Journal:  N Engl J Med       Date:  1972-08-10       Impact factor: 91.245

3.  Pure red blood cell aplasia and chronic lymphocytic leukemia.

Authors:  M D Abeloff; L Waterbury
Journal:  Arch Intern Med       Date:  1974-10

4.  Dihydrothymine from UV-irradiated DNA.

Authors:  T Yamane; B J Wyluda; R G Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  1967-08       Impact factor: 11.205

5.  T cell chronic lymphocytic leukemia: presence in bone marrow and peripheral blood of cells that suppress erythropoiesis in vitro.

Authors:  R Hoffman; S Kopel; S D Hsu; N Dainiak; E D Zanjani
Journal:  Blood       Date:  1978-07       Impact factor: 22.113

6.  Effect of peripheral blood lymphocytes from patients with aplastic anemia on granulocytic colony growth from HLA-matched and -mismatched marrows: effect of transfusion sensitization.

Authors:  J W Singer; J E Brown; M C James; K Doney; R P Warren; R Storb; E D Thomas
Journal:  Blood       Date:  1978-07       Impact factor: 22.113

7.  An assay for serum cytotoxicity against erythroid precursor cells in pure red cell aplasia.

Authors:  B Löwenberg; R Ghio
Journal:  Biomedicine       Date:  1977-11

8.  Pure red cell aplasia (PRCA): Response of three patients of cyclophosphamide and/or antilymphocyte globulin (ALG) and demonstration of two types of serum IgG inhibitors to erythropoiesis.

Authors:  A Marmont; C Peschle; M Sanguineti; M Condorelli
Journal:  Blood       Date:  1975-02       Impact factor: 22.113

9.  Autoimmune hemolytic anemia and periodic pure red cell aplasia in systemic lupus erythematosus.

Authors:  R J Meyer; R Hoffman; E D Zanjani
Journal:  Am J Med       Date:  1978-08       Impact factor: 4.965

10.  Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG.

Authors:  L Moretta; S R Webb; C E Grossi; P M Lydyard; M D Cooper
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

View more
  9 in total

1.  Pathology-important advances in clinical medicine: assessing fetal lung maturity.

Authors:  R K Wertz
Journal:  West J Med       Date:  1984-07

Review 2.  Management of chronic lymphocytic leukaemia.

Authors:  N Kalil; B D Cheson
Journal:  Drugs Aging       Date:  2000-01       Impact factor: 3.923

3.  Bone marrow aplasia in B cell chronic lymphocytic leukaemia: successful treatment with antithymocyte globulin.

Authors:  R Singal; D A Winfield; M Greaves
Journal:  J Clin Pathol       Date:  1991-11       Impact factor: 3.411

4.  Evidence for genetic restriction in the suppression of erythropoiesis by a unique subset of T lymphocytes in man.

Authors:  J M Lipton; L M Nadler; G P Canellos; M Kudisch; C S Reiss; D G Nathan
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

5.  Pathophysiologic Mechanisms And Management Of Large Granular Lymphocytic Leukemia Associated Pure Red Cell Aplasia.

Authors:  Zhi-Yuan Qiu; Rong Qin; Guang-Yu Tian; Yan Wang; Ye-Qing Zhang
Journal:  Onco Targets Ther       Date:  2019-10-04       Impact factor: 4.147

Review 6.  Autoimmune cytopenias in chronic lymphocytic leukemia.

Authors:  Giovanni D'Arena; Roberto Guariglia; Francesco La Rocca; Stefania Trino; Valentina Condelli; Laura De Martino; Vincenzo De Feo; Pellegrino Musto
Journal:  Clin Dev Immunol       Date:  2013-04-16

7.  Functional properties of a unique subset of cytotoxic CD3+ T lymphocytes that express Fc receptors for IgG (CD16/Leu-11 antigen).

Authors:  L L Lanier; T J Kipps; J H Phillips
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

8.  Inhibition of bone marrow colony formation by human natural killer cells and by natural killer cell-derived colony-inhibiting activity.

Authors:  G Degliantoni; B Perussia; L Mangoni; G Trinchieri
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

Review 9.  Biology of natural killer cells.

Authors:  G Trinchieri
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.